Position in SIGA
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$580,612
-$277,287 QoQ
Shares Held
159,509
-0.5% QoQ
Ownership
0.222%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 160 holders
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SIGA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $670,557,120 across 30 Drug Manufacturers - Specialty & Generic names. SIGA ranks #26 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
923,125 | $155,583,487 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
249,056 | $134,946,012 | |
| 3 | ALKS |
Alkermes plc.
|
2,421,016 | $126,861,238 | |
| 4 | ZTS |
Zoetis Inc.
|
1,435,652 | $103,165,952 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,114,912 | $33,902,039 | |
| 6 | LQDA |
Liquidia Corp
|
301,432 | $24,033,173 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,120,469 | $11,204,690 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
614,206 | $10,631,905 |
All Filings in SIGA
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $580,612 | 159,509 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $857,899 | 160,355 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $946,707 | 154,944 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,387,551 | 151,645 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $983,952 | 150,913 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $784,105 | 143,085 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $878,818 | 146,226 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $995,638 | 147,502 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $857,745 | 113,010 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $957,144 | 111,816 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $606,961 | 108,386 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $556,605 | 106,020 | Shares | Sole | 2023-11-13 | |
| 2023-03-31 | $862,143 | 149,938 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,170,854 | 294,953 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $998,111 | 96,904 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||